» Articles » PMID: 11487614

Amphetamine Distorts Stimulation-dependent Dopamine Overflow: Effects on D2 Autoreceptors, Transporters, and Synaptic Vesicle Stores

Overview
Journal J Neurosci
Specialty Neurology
Date 2001 Aug 7
PMID 11487614
Citations 96
Authors
Affiliations
Soon will be listed here.
Abstract

Amphetamine (AMPH) is known to raise extracellular dopamine (DA) levels by inducing stimulation-independent DA efflux via reverse transport through the DA transporter and by inhibiting DA re-uptake. In contrast, recent studies indicate that AMPH decreases stimulation-dependent vesicular DA release. One candidate mechanism for this effect is the AMPH-mediated redistribution of DA from vesicles to the cytosol. In addition, the inhibition of stimulation-dependent release may occur because of D2 autoreceptor activation by DA that is released via reverse transport. We used the D2 receptor antagonist sulpiride and mice lacking the D2 receptor to address this issue. To evaluate carefully AMPH effects on release and uptake, we recorded stimulated DA overflow in striatal slices by using continuous amperometry and cyclic voltammetry. Recordings were fit by a random walk simulation of DA diffusion, including uptake with Michaelis-Menten kinetics, that provided estimates of DA concentration and uptake parameters. AMPH (10 microm) promoted the overflow of synaptically released DA by decreasing the apparent affinity for DA uptake (K(m) increase from 0.8 to 32 microm). The amount of DA released per pulse, however, was decreased by 82%. This release inhibition was prevented partly by superfusion with sulpiride (47% inhibition) and was reduced in D2 mutant mice (23% inhibition). When D2 autoreceptor activation was minimal, the combined effects of AMPH on DA release and uptake resulted in an enhanced overflow of exocytically released DA. Such enhancement of stimulation-dependent DA overflow may occur under conditions of low D2 receptor activity or expression, for example as a result of AMPH sensitization.

Citing Articles

Genes, Cognition, and Their Interplay in Methamphetamine Use Disorder.

Khan R, Turner A, Berk M, Walder K, Rossell S, Guerin A Biomolecules. 2025; 15(2).

PMID: 40001609 PMC: 11852989. DOI: 10.3390/biom15020306.


Dopamine signaling enriched striatal gene set predicts striatal dopamine synthesis and physiological activity in vivo.

Sportelli L, Eisenberg D, Passiatore R, DAmbrosio E, Antonucci L, Bettina J Nat Commun. 2024; 15(1):3342.

PMID: 38688917 PMC: 11061310. DOI: 10.1038/s41467-024-47456-5.


Vesicular monoamine transporter-2 inhibitor JPC-141 prevents methamphetamine-induced dopamine toxicity and blocks methamphetamine self-administration in rats.

Chandler C, Nickell J, George Wilson A, Culver J, Crooks P, Bardo M Biochem Pharmacol. 2024; 228:116189.

PMID: 38580165 PMC: 11546627. DOI: 10.1016/j.bcp.2024.116189.


Co-targeting the kappa opioid receptor and dopamine transporter reduces motivation to self-administer cocaine and partially reverses dopamine system dysregulation.

Estave P, Albertson S, Karkhanis A, Jones S Sci Rep. 2024; 14(1):6509.

PMID: 38499566 PMC: 10948819. DOI: 10.1038/s41598-024-53463-9.


The influence of dopamine autoreceptors on temperament and addiction risk.

Zald D Neurosci Biobehav Rev. 2023; 155:105456.

PMID: 37926241 PMC: 11330662. DOI: 10.1016/j.neubiorev.2023.105456.


References
1.
Kuhr W, Ewing A, Near J, Wightman R . Amphetamine attenuates the stimulated release of dopamine in vivo. J Pharmacol Exp Ther. 1985; 232(2):388-94. View

2.
Clausing P, Gough B, Holson R, Slikker Jr W, Bowyer J . Amphetamine levels in brain microdialysate, caudate/putamen, substantia nigra and plasma after dosage that produces either behavioral or neurotoxic effects. J Pharmacol Exp Ther. 1995; 274(2):614-21. View

3.
Brahma B, Forman R, Stewart E, Nicholson C, Rice M . Ascorbate inhibits edema in brain slices. J Neurochem. 2000; 74(3):1263-70. DOI: 10.1046/j.1471-4159.2000.741263.x. View

4.
Jones S, Joseph J, Barak L, Caron M, Wightman R . Dopamine neuronal transport kinetics and effects of amphetamine. J Neurochem. 1999; 73(6):2406-14. DOI: 10.1046/j.1471-4159.1999.0732406.x. View

5.
Cardozo D, Bean B . Voltage-dependent calcium channels in rat midbrain dopamine neurons: modulation by dopamine and GABAB receptors. J Neurophysiol. 1995; 74(3):1137-48. DOI: 10.1152/jn.1995.74.3.1137. View